Drug Patent Watch

DECEMBER 12, 2024

This approach not only helps maintain market exclusivity but also ensures a steady revenue stream for pharmaceutical companies. Understanding the Pharmaceutical Market Dynamics The pharmaceutical industry is a complex ecosystem where branded drugs and generics coexist, each playing a vital role in patient care and market dynamics.

Licensing

Drug Patent Watch

DECEMBER 30, 2024

This article aims to provide a comprehensive overview of the key aspects of the regulatory framework, highlighting the requirements and challenges faced by pharmaceutical companies seeking to introduce generic drugs into the Japanese market. Retrieved from [link] Japan Pharmaceutical Manufacturers Association. Freyr Solutions.

Drug Development

Drug Patent Watch

AUGUST 5, 2025

"The Battle for Generic Ruzurgine: A Pharmaceutical Showdown In a move that could have far-reaching implications for the pharmaceutical industry, Supernus Pharmaceuticals, Inc. " #pharmaceuticals #genericdrugs #patentprotection #ADHDtreatment [link] Stay tuned for further updates on this developing story."

Pharmaceuticals

Drug Patent Watch

DECEMBER 9, 2024

In the vast realm of pharmaceutical research and development, there’s a fascinating intersection between ancient wisdom and modern science. “Pharmacognosy is the bridge between traditional medicine and modern pharmaceutical science, offering a treasure trove of potential new drugs waiting to be discovered.”

Drugs

Drug Patent Watch

JULY 15, 2025

"Breaking Down Barriers: How Mutual Recognition Agreements Can Revolutionize Generic Drug Approvals As the pharmaceutical industry continues to grapple with the complexities of global regulatory frameworks, a little-known solution is gaining traction: Mutual Recognition Agreements (MRAs).

Pharmaceutical Companies

FDA Law Blog: Biosimilars

MARCH 18, 2025

Specifically, the Court focused on the purpose: to compensate pharmaceutical companies for the effective truncation of their patent terms while waiting for regulatory approval of new drug applications. The Court thus explained that interpreting the patent in 35 U.S.C.

Pharmaceutical Companies

Drug Target Review

JULY 3, 2025

It is becoming increasingly evident that generative artificial intelligence (GenAI) is a resourceful tool for helping pharmaceutical companies reduce manual tasks required by clinical trials.

Drug Development

Drug Target Review

DECEMBER 11, 2024

For small- and medium-sized pharmaceutical companies, outsourcing represents a strategic leap forward, offering a gateway to unparalleled expertise and cutting-edge analytical technologies. Such an approach ensures reliable preclinical toxicology data and supports the transition of innovative therapies from the lab to clinical trials.

International

The Pharma Data

JUNE 25, 2025

Novartis Finalizes Acquisition of Regulus Therapeutics, Strengthening Its Renal Disease Portfolio with Promising ADPKD Therapy Novartis AG, a leading global pharmaceutical company, has officially completed its acquisition of Regulus Therapeutics Inc. , a biotechnology firm known for its expertise in microRNA-targeting therapies.

RNA

Drug Target Review

JULY 21, 2025

Prior to WuXi AppTec, Dr Li held scientific leadership roles in CROs and pharmaceutical companies in Canada and Japan. Her expertise spans CRO oversight, regulatory strategy and CTD-compliant submissions for INDs and NDAs. She holds a PhD in pharmacology from Japan, and an MD and MSc from China.

Drug Development

Drug Target Review

JULY 31, 2025

The scalability and cost-effectiveness of recombinant production have also democratised access to these improved antibodies, allowing academic labs and small biotech startups to leverage the same advanced tools once limited to large pharmaceutical companies.

Engineering

PPD

NOVEMBER 11, 2024

By accelerating timelines, anticipating challenges and alleviating bottlenecks, pharmaceutical companies and combined CDMO and CRO partners together can help ensure those potential treatments reach the patients who need them as efficiently as possible.

Drug Development

Drug Patent Watch

JANUARY 14, 2025

In the fast-paced world of pharmaceuticals, negotiations play a pivotal role in shaping the industry’s landscape. Let’s dive into the intricacies of pharmaceutical negotiations, exploring valuable lessons, current trends, and strategies for success.

Pharmaceuticals

Drug Patent Watch

AUGUST 5, 2025

"Patent Tussle Threatens to Upend Epilepsy Treatment Market: A High-Stakes Battle Between Supernus Pharmaceuticals and Appco Pharma is Raging in the Courts, with Implications for Patients and Pharmaceutical Companies Alike. Read the Full Story: [link] #pharmaceuticals #patentlaw #epilepsy"

Pharmaceuticals

Alta Sciences

JUNE 6, 2025

For biotechnology and pharmaceutical companies, automation can decrease their drug-to-market development time and remain financially competitive in an evolving market. My experience as an optimization scientist has shown how automation can be a valuable tool to support drug development for sponsors of all sizes.

Pharmacokinetics

Alta Sciences

JULY 3, 2025

In May 2025, Altasciences attended CPHI Americas in Philadelphia, where industry leaders, innovators, and stakeholders gathered to explore the latest advancements in pharmaceutical development technologies and connect with providers. Why does that matter? Beyond the science, what’s exciting is how this technology opens doors.

Small Molecule

The Pharma Data

JUNE 18, 2025

Backed by two leading pharmaceutical companies, Daiichi Sankyo and Merck, the study aims to validate ifinatamab deruxtecan as a new treatmen 100 49702 0 49702 0 0 110k 0 --:--:-- --:--:-- --:--:-- 110kt option for patients with advanced prostate cancer who have progressed beyond hormone therapy.

Trials

The Pharma Data

JUNE 24, 2025

Bayer and Tsinghua University Deepen Strategic Alliance to Advance Pharmaceutical Innovation in China Bayer and Tsinghua University (THU), two powerhouses in global pharmaceutical innovation and academic research, have announced a renewed commitment to their long-standing partnership.

Pharma R&D

The Pharma Data

JUNE 13, 2025

This includes assistance in intellectual property strategy, securing funding, developing business plans, and preparing for eventual collaboration with large pharmaceutical companies or investors. The main objective of MEDISO is to aid Japanese drug-discovery ventures in navigating the complex path toward commercial readiness.

Research

Drug Patent Watch

JUNE 9, 2025

"Navigating the Maze of Regulations: How Pharmaceutical Companies Can Safeguard Their Drug Portfolios As the pharmaceutical industry continues to evolve, regulatory environments are becoming increasingly complex.

Pharmaceutical Companies

Drug Patent Watch

AUGUST 11, 2025

"Revolutionizing the Way We Prescribe: How Data-Driven Insights Are Redefining Formulary Automation As healthcare costs continue to soar, pharmaceutical companies, payers, and providers are under increasing pressure to optimize formulary management.

Clinical Trials

thought leadership

FEBRUARY 10, 2025

For pharmaceutical companies, this shift presents both challenges and opportunities. In today's digital age, social media has transformed how businesses communicate with their audiences. Social media can significantly enhance brand visibility and patient engagement and have an impact on the overall healthcare sector.

Pharmaceutical Companies

SugarCone Biotech

JUNE 27, 2025

Finally, while there are clear front runners among the pharmaceutical companies developing targeted therapeutics for these antigens there are also emerging biotechs aggressively pursuing these targets. Each target and each therapeutic modality induces varying degrees of clinical efficacy, as well as causing toxicities.

Therapies

SugarCone Biotech

JUNE 19, 2025

Finally, while there are clear front runners among the pharmaceutical companies developing targeted therapeutics for these antigens there are also emerging biotechs aggressively pursuing these targets. Each target and each therapeutic modality induce varying degrees of clinical efficacy, as well as causing toxicities.

Therapies

Drug Target Review

JUNE 2, 2025

With a deep understanding of the industry’s complexities and the evolving market needs, he has been instrumental in providing innovative solutions for both biotech startups and large pharmaceutical companies. Meet Iwan Bertholjotti Iwan Bertholjotti is Senior Director of Commercial Development for Bioconjugates at Lonza.

Small Molecule

Drug Target Review

MARCH 4, 2025

The MyPhenome test has already gained traction among obesity specialists, particularly in Chicago and Florida, and Phenomix has formed strategic partnerships with multiple pharmaceutical companies to support clinical trials and further analyse obesity-related data.

Therapies

DrugBank

JUNE 18, 2025

While these regulations protect public health, they also introduce significant challenges for pharmaceutical researchers. This means pharmaceutical companies must remain vigilant and adaptable to comply with evolving regulations. The extensive data requirements for regulatory submissions further complicate the process.

Drug Development

Drug Patent Watch

FEBRUARY 27, 2025

Navigating the Complex World of Global Drug Patents: Strategies and Challenges Ahead As a pharmaceutical professional, you know how crucial it is to protect your innovative drug patents in the global market. This is a nightmare scenario for any pharmaceutical company, and it's a reality that many face every day.

Marketing

ACTO

DECEMBER 17, 2024

The stakes for AI adoption in the pharmaceutical industry have never been higher. A survey of healthcare and life science companies found that 93% of these companies expect to increase their spend in 2025. How can they ensure that these solutions meet the stringent requirements of the biopharma industry?

Government

Drug Target Review

JULY 14, 2025

The pharmaceutical industry faces a persistent challenge: despite significant investments in drug development, a substantial proportion of promising candidates fail due to unforeseen toxicity issues.

Drugs

Drug Target Review

MARCH 3, 2025

However, promising pilot data from ongoing collaborations with pharmaceutical companies suggest that brain organoids are set to become a valuable tool in preclinical research. . “There’s still a long way to go to convince pharma that this model is really useful,” he acknowledges.

Disease

Drug Target Review

JUNE 14, 2025

I began developing my own scripts to streamline processes, which led me into scientific informatics, where I worked with pharmaceutical companies on cheminformatics. I began in bioinformatics, conducting lab-based genomics work but soon felt the need to dive deeper into the computational side.

Laboratories

Drug Target Review

JUNE 18, 2025

However, when that pressure is compounded by political shifts, market volatility and rising expectations from the global pharmaceutical industry, the old ways of working start to crack. To remain competitive, pharmaceutical teams must adopt bold thinking, foster agile collaboration, and take smarter, more calculated risks.

Drugs

The Pharma Data

JULY 3, 2025

NASDAQ: SBFM), a pharmaceutical company focused on developing and commercializing life-saving medicines across oncology, antiviral therapies, and other therapeutic areas, has announced the commercial launch of its first biosimilar drug, NIOPEG® , in Canada.

Marketing

Drug Patent Watch

DECEMBER 17, 2024

Let’s dive into the world of pharmaceutical outsourcing and explore why adaptability is the key to success. The Evolving Role of CDMOs in the Pharmaceutical Industry Gone are the days when CDMOs were mere service providers. Responding to Market Demands The pharmaceutical market is notoriously unpredictable.

Pharmaceuticals

Drug Patent Watch

FEBRUARY 13, 2025

The Unsung Heroes of Generic Drug Development: The Power of Partnerships As we navigate the complex landscape of pharmaceuticals, it's easy to overlook the crucial role that partnerships play in bringing affordable, life-saving medications to market. When it comes to developing generic drugs, partnerships can take many forms.

Drug Development

Codon

NOVEMBER 3, 2024

Based on these results, Waksman asked the pharmaceutical company Merck to mass-produce streptomycin for further tests that could provide clearer evidence of its efficacy and safety. But now, researchers are increasingly using machine learning to speed up pharmaceutical breakthroughs.

Vaccine